Extended stability of the rituximab biosimilar CT-P10 in its opened vials and after dilution and storage in polyolefin bags

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

Jonathan Edwards, L Szczepański, Jacek Szechiński et al. · New England Journal of Medicine · 2004 · 2.6K citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Induction and analysis of aggregates in a liquid IgG1-antibody formulation

Hanns‐Christian Mahler, Robert Müller, Wolfgang Frieβ et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2005 · 305 citations

Pharmacy, Biochemistry, Immunology +11

Structural properties of monoclonal antibody aggregates induced by freeze–thawing and thermal stress

Andrea Hawe, Julia Christina Kasper, Wim Jiskoot · European Journal of Pharmaceutical Sciences · 2009 · 251 citations

Pharmacy, Biochemistry, Molecular Biology +17

The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein–kinase–dependent mechanism

Irene M. Pedersen, Anne Mette Buhl, Pia Klausen et al. · Blood · 2002 · 220 citations · Full text

Life Sciences, Immunology, Oncology +14

Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab

Jan Marinus Visser, Isabel Feuerstein, Thomas Stangler et al. · BioDrugs · 2013 · 179 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17